Clinical Trials Logo

Weight-Gain Prevention clinical trials

View clinical trials related to Weight-Gain Prevention.

Filter by:
  • None
  • Page 1

NCT ID: NCT06148246 Recruiting - Physical Inactivity Clinical Trials

Family Fit Iterative App Development

Start date: January 18, 2024
Phase: N/A
Study type: Interventional

The overall aim of this study is to test the acceptability and usability of a mobile application (app) for family-based physical activity and weight gain prevention among parent/guardian and child (ages 9-12 years) dyads.

NCT ID: NCT05693896 Not yet recruiting - Obesity Clinical Trials

Treating Binge Eating and Obesity Digitally in Black Women

Start date: January 2025
Phase: N/A
Study type: Interventional

More than 30% of Black women with obesity binge eat. Binge eating may increase the risk for the development of metabolic syndrome and binge-eating-disorder (BED), which is associated with severe obesity. Though several effective treatments for binge eating exist, Black women have not fared well. Not only has their inclusion in treatment trials been limited, but when participating, they are more likely to drop out, and/or lose less weight, compared to their White counterparts. Furthermore, treatment for binge eating is often not available in primary care and community-based settings places where Black women are more likely to receive treatment for their eating and weight-related concerns. Currently, there is scant intervention research to treat binge eating in Black women. With the highest rates of obesity (57%) nationally, Black women are in need of culturally-relevant treatments for binge eating and weight gain prevention. Given the established relationship between frequent binge eating and subsequent weight gain, addressing binge eating among Black women with obesity is imperative.

NCT ID: NCT05200520 Completed - Obesity Clinical Trials

Improving Appetite Regulation in Patients With Obesity

Start date: March 5, 2022
Phase: N/A
Study type: Interventional

Over 70% of U.S. adults have overweight or obesity. Currently, the most efficacious behavioral intervention for obesity is standard behavioral treatment (SBT), often composed of group sessions, calorie goals, and physical activity goals. With this approach, participants often lose 8-10% of the person's baseline weight, and also decrease risk for cardiovascular disease. Long-term weight loss, however, is limited; many participants return to baseline weight within five years following treatment. One reason SBT may not create long-term weight loss may be due to treatment components that teach participants to rely on external methods for changing eating decisions (e.g., counting calories, restricting certain foods), rather than internal cues of hunger and satiety. Because individuals with obesity report significant challenges with adhering to these cues, augmenting behavioral interventions with appetite self-regulation training may be a solution. Thus, the investigator propose to examine the feasibility and acceptability of a 6-month remotely-delivered appetite regulation + lifestyle modification intervention to treat obesity.

NCT ID: NCT03531112 Terminated - Weight Loss Clinical Trials

Reducing Binge Eating to Prevent Weight Gain in Black Women

Start date: January 12, 2019
Phase: N/A
Study type: Interventional

The purpose of the proposed study is to pilot a 6-month, cognitive-behavioral binge eating intervention, Appetite Awareness Training (AAT) to reduce binge eating and prevent weight gain for Black women with a BMI > 25 kg/m^2 and with weekly binge eating episodes. Intervention participants will receive a 8-week group AAT intervention, and will also receive bluetooth-connected scales for daily weighing. Participants will also receive tailored feedback on self-weighing frequency and weight change. The investigators will follow-up with participants at six months.

NCT ID: NCT00455442 Completed - Clinical trials for Weight-Gain Prevention

A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain

Start date: March 2007
Phase: Phase 2
Study type: Interventional

This is a two-week study testing the efficacy and safety of mifepristone in the prevention of olanzapine-induced weight gain in healthy male volunteers by measuring changes in body weight and BMI.